Intas Pharmaceuticals Ltd. Sets World Record for Largest Vulture Conservation Awareness Drive Engaging Over 8,000 Veterinary Professionals
Ahmedabad, India: Intas Pharmaceuticals Ltd. has been recognized by the World Book of Records UK, for organizing the World’s Largest Vulture Conservation Awareness Drive, engaging more than 8,000 veterinary professionals across India under its ‘Power of Vet’ campaign an initiative by Intas’ flagship brands, Melonex and Maxxtol.
The nationwide movement brought together veterinarians to reaffirm their commitment to ecological safety and the protection of vulture’s nature’s vital clean-up crew. The initiative emphasized the urgent need to eliminate toxic non-steroidal anti-inflammatory drugs (NSAIDs) such as diclofenac, aceclofenac, ketoprofen, and nimesulide, which have been linked to vulture population declines. As part of the campaign, thousands of participants took the Vulture-Safe Prescription Pledge, committing to use only meloxicam and tolfenamic acid, the two NSAIDs scientifically proven to be safe for vultures.
Binish Chudgar, Chairman and Managing Director of Intas Pharmaceuticals Ltd., stated, “Together, we are safeguarding the silent sentinels of our ecosystem and promoting a healthier future.”
Vijay Teng, President, Global Animal Health Business, Intas Pharmaceuticals Ltd., remarked, “Every veterinary prescription can either harm or protect vultures. By sharing the science behind vulture-safe NSAIDs, we are turning awareness into action.”
Raja Mukherjee, Executive Vice President, Intas Animal Health, added, “Veterinarians’ choices have far-reaching ecological impact. Promoting vulture-safe NSAIDs ensures responsible care for both livestock and biodiversity.” This recognition underscores Intas Pharmaceuticals Ltd.’s unwavering commitment to scientific integrity, ecological responsibility, and the One Health principle, setting a new benchmark for the pharmaceutical industry’s role in wildlife conservation and environmental sustainability.
